<DOC>
	<DOCNO>NCT00796354</DOCNO>
	<brief_summary>Multi-centre , double-blind , randomise , placebo-controlled , parallel group study .</brief_summary>
	<brief_title>Constipation Associated With Irritable Bowel Syndrome ( IBS-C )</brief_title>
	<detailed_description>Patients treat 28 day , clinical assessment carry 2 visit . Follow-up perform via telephone specific interval study determine outcome unresolved AEs , new drug-related AEs pregnancy . During run-in period treatment phase , patient prohibit take prescription counter ( OTC ) laxative medication constipate medication . Prescription OTC medication related constipation permit must fully document , change ( e.g. , dosage , regimen ) limit much possible .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Male female age 18 80 year inclusive . Written inform consent obtain . Females childbearing potential must employ adequate method contraception must undergo pregnancy test Randomisation Visit . Willing , able competent complete entire study comply study instruction . Patients &gt; 50 year old undergone colonoscopy computerise tomography ( CT ) onset IBSC symptom within last 5 year . Patient diagnose IBSC use Rome III criterion last 3 month , symptom onset least 6 month prior diagnosis . History evidence organic disease large bowel , intestinal perforation obstruction due structural functional disorder gut wall , ileus , severe inflammatory condition intestinal tract Crohn 's disease , complicate diverticulitis , ulcerative colitis , toxic megacolon occlusive subocclusive syndrome . Abdominal pain unknown cause , related IBS . Previous major abdominal surgery . IBS subtype IBSC . Known allergy polyethylene glycol ( PEG ) 3350 know hypersensitivity active substance . Laxative , drug alcohol abuse ( recent history within previous 12 month ) . Pregnant lactating female . Severe acute disease within 2 week prior start study . Patients type I II diabetes . Use investigational drug , prescribe OTC medication affect gastrointestinal function anticholinergic , prokinetics , drug affect motility , anthraquinones , opioids , ondansetron 5HT3 antagonist . Incomplete Patient Diary Card runin period . The occurrence diarrhoea* runin period . Patients abnormal laboratory test , proctoscopy /abdominal ultrasound , colonoscopy , sigmoidoscopy CT require investigation . Patients condition , , Investigator 's may put patient significant risk , may confound study result , may interfere significantly result study . Participation another clinical study drug device parallel less 1 month study entry , previous participation study . Employees Investigator study site direct involvement propose study study direction Investigator study site , well family member employee Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Constipation</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
</DOC>